Has Science Outgrown the Nobels?

Amid Nobel Prize announcements this week, critics find awarding individuals in specific disciplines at odds with today’s interdisciplinary, team-led research.

Written byBeth Marie Mole
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Three Nobel Laureates in Physics. From left to right: Albert A. Michelson, Albert Einstein and Robert A. Millikan. Wikimedia, Smithsonian InstitutionThe Nobel committees’ cap of three winners per prize will unavoidably leave out critical contributors to profound discoveries as more scientists work in diverse teams, according to a handful of editorials and opinion pieces released this week (October 8).

An editorial in Scientific American, published Monday (October 8), argued that the days of the lone, brilliant scientist are over. “Whereas a century ago a patent clerk famously divined the theory of relativity in his spare time, discovering a Higgs boson requires decades of planning and the efforts of 6,000 researchers,” the editors wrote. “No one person—no troika, even—can legitimately claim all the credit.”

The editorial directly recounts the argument that Athene Donald, an experimental physicist at the University of Cambridge, made in a commentary in the Telegraph last month (September 17), also citing the Higgs boson discovery as an exemplary challenge to the Nobel committee’s three-awardee limit. “It’s not just theorists who contributed to the ‘discovery’ of the Higgs Boson,” she wrote. “None of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies